STRATA CRITICAL MEDICAL, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
STRATA CRITICAL MEDICAL, INC. (SRTA) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $7.34 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-04
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $7.34M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $5.91M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $1.49M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $2.46M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One | Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed |
|---|---|---|
| 2026-06-30 | $7.34M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $5.91M 10-K · filed 2026-03-03 | |
| 2025-09-30 | $1.49M 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $2.46M 10-K · filed 2025-03-13 | |
| 2023-12-31 | $4.44M 10-K · filed 2024-03-12 | |
| 2022-12-31 | $6.17M 10-K · filed 2023-03-16 | |
| 2022-09-30 | $7.18M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.96M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $3.94M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $3.89M 8-K · filed 2023-01-10 | $3.93M 10-QT · filed 2022-02-10 |
| 2021-09-30 | $1.50M 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |